Posts

Assured Raises $19 Million Series A to Accelerate AI-Driven Provider Credentialing

Karoo Health Raises $16.2 Million to Expand AI‑Driven Cardiovascular Care Platform

RQ Bio raises $115M to advance long‑acting flu prevention antibody into clinic

Boundless Bio agrees to reverse merger with Serapha Bio in $230M gene‑editing deal

Obesity care startup Ilant Health raises $15M Series A for AI‑supported precision‑obesity‑care platform

Stipple Bio Launches with $100M Series A to Target Novel Oncology Proteins

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

Bioliberty Raises $10.2 Million for Functional Intelligence in Post-Acute Care

R1 Therapeutics Raises $77.5M Series A to Advance Kidney Disease Treatment AP306

R1 Therapeutics Launches with Oversubscribed $77.5M Series A to Advance Phase 2b Trial for Kidney Disease Drug AP306

Slate Medicines Launches with $130M Series A for Anti-PACAP Migraine Drug from China's DartsBio

BioMarin Veterans Launch Mendra Biotech with $82M for AI-Driven Rare Disease Drugs

BioMarin Veterans Launch Mendra Biotech with $82M for AI-Driven Rare Disease Drugs

Kinaset Therapeutics Raises $103M to Advance Inhaled Asthma Drug

Kinaset Therapeutics Raises $103M to Advance Inhaled Asthma Drug

Kinaset Therapeutics Raises $103M to Advance Inhaled Asthma Drug

Berkeley startup raises $106.5M for all‑RNA ‘jumping gene’ therapies

Ambros Therapeutics launches with $125M to develop non-opioid chronic pain drug neridronate

Zag Bio Launches with $80M to Teach the Immune System to Make Better Tregs

Apptronik Raises $350 Million Series A to Scale AI Humanoid Robot Production